Experiment 330234

Worktypes

PHARMACEUTICAL FORMULATION OFEFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN HUMANSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)

Compounds isolated

HINOKITIOLTHYMOLUNDECANOIC ACID

Details

PropertyValue
Pharmacology
ANTIFUNGAL ACTIVITY
Administration routeEXTERNAL
OrganismEmpty organism
CitationKAFUKU,A:. (1975). PHARMACEUTICAL COMPOSITION FOR TREATING DERMATOMYCOSIS.. ()
Amount utilized
Compound isolated
DiseaseDERMATOMYCOSIS
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT